Drug Topics E-News:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Unsubscribe from this list.
Modern Medicine Network
  Drug Topics E-News
 
JUNE 23, 2009
IN THIS ISSUE
2008 top branded drugs
Groups want research
Bill fights bonds
CVS merger questioned

2008 Top 200 branded drugs by retail dollars
Find out more about the 200 top branded drugs by retail dollars.
More...

Pharmacy groups battle for inclusion in comparative research studies
The stimulus package passed in February has catapulted the field of comparative effectiveness research into a defining moment. More...

Bill would exempt pharmacists from posting Part B surety bonds
Pharmacies that provide Medicare Part B Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) would be exempt from posting $50,000 surety bonds under legislation recently introduced by U.S. Senators Jon Tester (D-MT) and Pat Roberts (R-KS). More...

Update: NCPA accuses CVS of questionable marketing practices
More than 80 community pharmacists from the National Community Pharmacists Association (NCPA) and several patients met with the Federal Trade Commission (FTC) May 13 to discuss concerns about the impact of the March 2007 CVS/Caremark merger and to urge the FTC to re-examine it. More...

Listen to Drug Topics Radio
Listen to what pharmacy professionals have to say about trends, regulation, and other issues in their field on Drug Topics radio.

Key Topic Updates
Issues & Trends
 
Professional
 
Clinical
 
Technology
 
Regulatory & Law

Key Topic Updates

Survey
Are more pharmacy schools needed in the United States?
27%   Yes
73%   No

This month we would like to know...

Do you believe you've lost business due to Internet pharmacies?
Click here to vote


Contact Us
Click here to learn more about the Drug Topics editorial team.

Click here to contact the Drug Topics editorial team.

Click here to contact the Drug Topics sales team.

Click here to learn about direct mail, reprints and classifieds in Drug Topics.

Drug Topics Digital Edition
Click here to to view the most recent issue.

Click here to subscribe.


You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list click here.

To ensure delivery to your Inbox, please add %%email.list%% to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.